Tue. 14 May 2024, 4:42pm ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
TFF Pharmaceuticals (NASDAQ:TFFP) reported quarterly losses of $(2.40) per share which missed the analyst consensus estimate of $(2.26) by 6.19 percent. The company reported quarterly sales of $203.27 thousand which beat the analyst consensus estimate of $75.00 thousand by 171.03 percent. This is a 295.25 percent increase over sales of $51.43 thousand the same period last year.